[{"NetIncomeLossConverted_1_Q2_USD":-15203000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q2_shares":217684000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":218784000.0,"CommonStockSharesConverted_0_Q2_shares":218903097.0,"Assets_0_Q2_USD":3307430000.0,"RevenuesConverted_3_Q2_USD":1877193000.0,"RevenuesConverted_1_Q2_USD":620643000.0,"EarningsPerShareBasic_1_Q2_USD":-0.07,"StockholdersEquity_0_Q2_USD":2390833000.0,"EarningsPerShareDiluted_3_Q2_USD":-2.05,"EarningsPerShareDiluted_1_Q2_USD":-0.07,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q2_USD":-231920000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q2_shares":217684000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":218784000.0,"NetIncomeLossConverted_3_Q2_USD":-445547000.0,"CommonStockSharesOutstanding_0_Q2_shares":218903097.0,"EarningsPerShareBasic_3_Q2_USD":-2.05,"Ticker":"INCY","CIK":"879169","name":"INCYTE CORP","OfficialName":"Incyte Corp. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"17588712770.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"SP500","filed":"20201105"}]